How HealthLinkNow can provide online patient consultations
The American Telemedicine Association (ATA) has awarded its second Accreditation for Online Patient Consultations to HealthLinkNow, Inc., a fully-integrated online network of psychiatrists and therapists providing mental health services across multiple states. In its first five months of operation, nearly 300 organizations have registered for the ATA program.
“In 2015, we estimate that over 800,000 patient consultations will take place online,” said Jonathan Linkous, CEO of ATA. “It is critical to ensure that online health care services are following the necessary standards, guidelines and laws to provide safe care to American consumers.”
“The ATA accreditation program promotes quality health care for patients. People want reassurance that they have access to quality care and physician/providers want secure health IT systems that work,” said Barb Johnston, CEO of HealthLinkNow. “ATA’s Accreditation Program has set the telemedicine industry standard for patient safety and service transparency. We are honored to be included in this accredited group.”
The ATA accreditation program recognizes U.S. health care entities providing real-time, online consultations directly to the patient that meet specific standards. Designed by experts in the field, ATA’s Accreditation Program for Online Patient Consultations has been developed to establish standard criteria regarding the security of patient information, transparency in pricing and operations, qualifications and licensing of providers and clinical practices and guidelines.
RELATED TOPIC: Don't overlook how critical patient privacy is
In addition to providing consumers with a sense of security, ATA’s Accreditation Program for Online Patient Consultations provides benchmarks for organizations building an online practice, and also provides reassurance for payers that the virtual services they are reimbursing are safe and of high quality.
HealthLinkNow is listed on SafeOnlineHealth.org, a resource to help consumers better understand the growing use of telecommunications in the delivery of healthcare services. In addition, visitors may learn more about online healthcare and browse accredited services.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”